James Stephen Love MD , Michael Siegel DO , Meredith Yellen MD , Jeffrey Rebhun MD , Asim Shuja MD
{"title":"Comparison of quality performance metrics in screening and surveillance colonoscopy: a single-center experience","authors":"James Stephen Love MD , Michael Siegel DO , Meredith Yellen MD , Jeffrey Rebhun MD , Asim Shuja MD","doi":"10.1016/j.igie.2024.08.007","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Aims</h3><div>Screening colonoscopy guidelines recommend a minimum adenoma detection rate (ADR) of 35%. There are no established benchmarks for surveillance colonoscopies, and data surrounding the utility of other quality metrics are limited. We aimed to define the relationship between ADR and alternative quality measures in the setting of screening and surveillance colonoscopies and to determine whether validated screening quality benchmarks can be extrapolated to surveillance procedures.</div></div><div><h3>Methods</h3><div>A retrospective review of outpatient screening and surveillance colonoscopies at a tertiary health center was performed. ADR, adenomas per colonoscopy, adenomas per positive participant, polyp detection rate, right-sided polyp detection rate, and colonoscopy withdrawal times (CWTs) were analyzed for screening and surveillance colonoscopies.</div></div><div><h3>Results</h3><div>In total, 2646 procedures (1884 screening, 762 surveillance) were analyzed. Surveillance ADR (CADR) was higher than screening ADR (65.6% ± 0.02% vs 47.0% ± 0.01%; <em>P</em> < .001). All alternate quality measures except CWT were higher in surveillance procedures. Among surveillance procedures, there was a strong correlation between CADR and polyp detection rate (<em>r</em> = .956, <em>P</em> < .01) and right-sided polyp detection rate (r = .771, <em>P</em> = .003); correlations between CADR and other alternate quality measures were not significant.</div></div><div><h3>Conclusions</h3><div>Colonoscopy quality measures were significantly higher in surveillance procedures compared with screening procedures despite similar CWTs. Higher benchmarks should be considered to ensure quality surveillance colonoscopies.</div></div>","PeriodicalId":100652,"journal":{"name":"iGIE","volume":"4 1","pages":"Pages 26-30"},"PeriodicalIF":0.0000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"iGIE","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949708624001122","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background and Aims
Screening colonoscopy guidelines recommend a minimum adenoma detection rate (ADR) of 35%. There are no established benchmarks for surveillance colonoscopies, and data surrounding the utility of other quality metrics are limited. We aimed to define the relationship between ADR and alternative quality measures in the setting of screening and surveillance colonoscopies and to determine whether validated screening quality benchmarks can be extrapolated to surveillance procedures.
Methods
A retrospective review of outpatient screening and surveillance colonoscopies at a tertiary health center was performed. ADR, adenomas per colonoscopy, adenomas per positive participant, polyp detection rate, right-sided polyp detection rate, and colonoscopy withdrawal times (CWTs) were analyzed for screening and surveillance colonoscopies.
Results
In total, 2646 procedures (1884 screening, 762 surveillance) were analyzed. Surveillance ADR (CADR) was higher than screening ADR (65.6% ± 0.02% vs 47.0% ± 0.01%; P < .001). All alternate quality measures except CWT were higher in surveillance procedures. Among surveillance procedures, there was a strong correlation between CADR and polyp detection rate (r = .956, P < .01) and right-sided polyp detection rate (r = .771, P = .003); correlations between CADR and other alternate quality measures were not significant.
Conclusions
Colonoscopy quality measures were significantly higher in surveillance procedures compared with screening procedures despite similar CWTs. Higher benchmarks should be considered to ensure quality surveillance colonoscopies.
背景和目的筛选结肠镜检查指南建议腺瘤检出率(ADR)最低为35%。目前还没有结肠镜检查监测的既定基准,有关其他质量指标效用的数据也很有限。我们的目的是确定在筛查和监测结肠镜检查中,不良反应和其他质量措施之间的关系,并确定有效的筛查质量基准是否可以外推到监测程序中。方法对某三级卫生中心门诊筛查和结肠镜检查进行回顾性分析。分析不良反应(ADR)、每次结肠镜检查腺瘤数、每次阳性参与者的腺瘤数、息肉检出率、右侧息肉检出率和结肠镜停镜次数(CWTs),用于结肠镜筛查和监测。结果共分析2646例,其中筛查1884例,监测762例。监测ADR (CADR)高于筛查ADR(65.6%±0.02% vs 47.0%±0.01%);P & lt;措施)。除CWT外,所有替代质量措施在监督程序中均较高。在监测程序中,CADR与息肉检出率有很强的相关性(r = .956, P <;.01)、右侧息肉检出率(r = .771, P = .003);CADR与其他替代质量测量之间的相关性不显著。结论尽管CWTs相似,但监测程序的结肠镜检查质量指标明显高于筛查程序。应考虑更高的基准,以确保结肠镜检查监测的质量。